Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)

被引：4

作者：

Yang, Yue ^{[1
]}

Luo, Yi-Dan ^{[1
]}

Zhang, Chen-Bo ^{[1
]}

Xiang, Yang ^{[1
,2
]}

Bai, Xin-Yue ^{[1
]}

Zhang, Die ^{[1
]}

Fu, Zhao-Ying ^{[1
]}

Hao, Ruo-Bing ^{[1
]}

Liu, Xiao-Long ^{[1
]}

机构：

[1] Yanan Univ, Sch Med, Yanan 716000, Peoples R China

[2] Yanan Univ, Coll Phys Educ, Yanan 716000, Peoples R China

来源：

ACS OMEGA | 2024年 / 9卷 / 32期

关键词：

RESPIRATORY SYNDROME-CORONAVIRUS; PAPAIN-LIKE PROTEASE; COVALENT INHIBITORS; WITHANIA-SOMNIFERA; DISCOVERY; DESIGN; AGLYCONE; BAICALIN;

D O I：

10.1021/acsomega.4c03023

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Since 2019, the novel coronavirus (SARS-CoV-2) has caused significant morbidity and millions of deaths worldwide. The Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 and its variants, has further highlighted the urgent need for the development of effective therapeutic agents. Currently, the highly conserved and broad-spectrum nature of main proteases (M-pro) renders them of great importance in the field of inhibitor study. In this study, we categorize inhibitors targeting M-pro into three major groups: mimetic, nonmimetic, and natural inhibitors. We then present the research progress of these inhibitors in detail, including their mechanism of action, antiviral activity, pharmacokinetic properties, animal experiments, and clinical studies. This review aims to provide valuable insights and potential avenues for the development of more effective antiviral drugs against SARS-CoV-2.

引用

页码：34196 / 34219

页数：24

共 50 条

[1] The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022
Pang, Xiaojing
Liu, Yang
Li, Hua
Chen, Lixia
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
[2] Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents
Zagorska, Agnieszka
Czopek, Anna
Fryc, Monika
Jonczyk, Jakub
BIOMOLECULES, 2024, 14 (07)
[3] Research Progress of Antiviral Drug Targeting the Main Protease of SARS-CoV-2
Wang, Chunxia
Hu, Xiaodong
Xu, Bin
Cao, Chunyang
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2022, 42 (07) : 1974 - 1999
[4] Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
Katre, Soumya Gulab
Asnani, Alpana Jagdish
Pratyush, Kumar
Sakharkar, Nilima Gangadhar
Bhope, Ashwini Gajanan
Sawarkar, Kanchan Tekram
Nimbekar, Vaibhav Santosh
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 8 (01)
[5] Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
Diogo, Marcel Arruda
Cabral, Augusto Gomes Teixeira
de Oliveira, Renata Barbosa
PATHOGENS, 2024, 13 (10):
[6] Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review
Xiao, Ya-Qi
Long, Jiao
Zhang, Shuang-Shuang
Zhu, Yuan -Yuan
Gu, Shuang-Xi
BIOORGANIC CHEMISTRY, 2024, 147
[7] Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
Azevedo, Pedro Henrique R. de A.
Camargo, Priscila G.
Constant, Larissa E. C.
Costa, Stephany da S.
Silva, Celimar Sinezia
Rosa, Alice S.
Souza, Daniel D. C.
Tucci, Amanda R.
Ferreira, Vivian N. S.
Oliveira, Thamara Kelcya F.
Borba, Nathalia R. R.
Rodrigues, Carlos R.
Albuquerque, Magaly G.
Dias, Luiza R. S.
Garrett, Rafael
Miranda, Milene D.
Allonso, Diego
Lima, Camilo Henrique da S.
Muri, Estela Maris F.
SCIENTIFIC REPORTS, 2024, 14 (01):
[8] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
Sharma, Shilpa
Deep, Shashank
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07) : 3003 - 3010
[9] The Discovery of Novel Small Oxindole-Based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro)
Alzyoud, Lara
Mahgoub, Radwa E.
Mohamed, Feda E.
Ali, Bassam R.
Ferreira, Juliana
Rabeh, Wael M.
Atatreh, Noor
Ghattas, Mohammad A.
CHEMISTRY & BIODIVERSITY, 2023, 20 (11)
[10] Progress of SARS-CoV-2 Main protease peptide-like inhibitors
Liu, Xiaoyong
Ren, Xiaoli
Hua, Miao
Liu, Fang
Ren, Xiaoping
Sui, Chaoya
Li, Qing
Luo, Fen
Jiang, Zhiyong
Xia, Ziqiao
Chen, Jingxia
Yang, Bing
CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)

← 1 2 3 4 5 →